Efficacy of five 'sporicidal' surface disinfectants against Clostridioides difficile spores in suspension tests and 4-field tests.

4-field test C. difficile Glutaraldehyde Peracetic acid Sporicidal activity Suspension test

Journal

The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 31 08 2021
revised: 03 01 2022
accepted: 13 01 2022
pubmed: 26 1 2022
medline: 1 4 2022
entrez: 25 1 2022
Statut: ppublish

Résumé

A sporicidal surface disinfection is recommended both for the outbreak and the endemic setting but a comparative evaluation on the efficacy of 'sporicidal' surface disinfectants using suspension tests and 4-field tests has not been performed. To determine the efficacy of five 'sporicidal' surface disinfectants (three ready-to-use wipes (A, B, E), two concentrates (C, D) based on peroxides or aldehydes against C. difficile spores. The efficacy was determined under clean conditions using a suspension test and the 4-field test. Each test was performed in duplicate in two separate laboratories. Wipes were wrung to collect the solution for the suspension tests. Product A (peracetic acid; 5 min), product C (peracetic acid; 2% solution in 15 min or 1% solution in 30 min) and product D (peracetic acid; only 2% solution in 15 min) were effective with at least a 4 log Not all surface disinfectants with a sporicidal claim were effective against C. difficile spores in standardized suspension tests and in the 4-field test. In clinical practice preference should be given to products that reliably pass the efficacy criteria of both types of tests.

Sections du résumé

BACKGROUND BACKGROUND
A sporicidal surface disinfection is recommended both for the outbreak and the endemic setting but a comparative evaluation on the efficacy of 'sporicidal' surface disinfectants using suspension tests and 4-field tests has not been performed.
AIM OBJECTIVE
To determine the efficacy of five 'sporicidal' surface disinfectants (three ready-to-use wipes (A, B, E), two concentrates (C, D) based on peroxides or aldehydes against C. difficile spores.
METHODS METHODS
The efficacy was determined under clean conditions using a suspension test and the 4-field test. Each test was performed in duplicate in two separate laboratories. Wipes were wrung to collect the solution for the suspension tests.
RESULTS RESULTS
Product A (peracetic acid; 5 min), product C (peracetic acid; 2% solution in 15 min or 1% solution in 30 min) and product D (peracetic acid; only 2% solution in 15 min) were effective with at least a 4 log
CONCLUSIONS CONCLUSIONS
Not all surface disinfectants with a sporicidal claim were effective against C. difficile spores in standardized suspension tests and in the 4-field test. In clinical practice preference should be given to products that reliably pass the efficacy criteria of both types of tests.

Identifiants

pubmed: 35077809
pii: S0195-6701(22)00025-1
doi: 10.1016/j.jhin.2022.01.010
pii:
doi:

Substances chimiques

Disinfectants 0
Peracetic Acid I6KPI2E1HD

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

140-147

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

S Gemein (S)

Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany; VAH Ring Trial Steering Committee of the Association for Applied Hygiene (VAH), Bonn, Germany. Electronic address: stefanie.gemein@ukbonn.de.

R Andrich (R)

Robert Koch-Institut, Abt. 1 Infektionskrankheiten, FG 14 Angewandte Infektions- und Krankenhaushygiene, Berlin, Germany.

B Christiansen (B)

ZE Medizinaluntersuchungsamt und Hygiene, University Hospital Schleswig-Holstein, Kiel, Germany.

M Decius (M)

ZE Medizinaluntersuchungsamt und Hygiene, University Hospital Schleswig-Holstein, Kiel, Germany.

M Exner (M)

Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany.

B Hunsinger (B)

VAH Ring Trial Steering Committee of the Association for Applied Hygiene (VAH), Bonn, Germany.

E Imenova (E)

HygCen Germany GmbH, Schwerin, Germany.

G Kampf (G)

Institute for Hygiene and Environmental Medicine, University Medicine Greifswald, Greifswald, Germany.

T Koburger-Janssen (T)

Hygiene Nord GmbH, Greifswald, Germany.

K Konrat (K)

Robert Koch-Institut, Abt. 1 Infektionskrankheiten, FG 14 Angewandte Infektions- und Krankenhaushygiene, Berlin, Germany.

H Martiny (H)

VAH Ring Trial Steering Committee of the Association for Applied Hygiene (VAH), Bonn, Germany.

M Meckel (M)

IKI Institut für Krankenhaushygiene und Infektionskontrolle GmbH, Gießen, Germany.

N T Mutters (NT)

Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany.

F-A Pitten (FA)

IKI Institut für Krankenhaushygiene und Infektionskontrolle GmbH, Gießen, Germany.

S Schulz (S)

HygCen Germany GmbH, Schwerin, Germany.

I Schwebke (I)

Robert Koch-Institut, Abt. 1 Infektionskrankheiten, FG 14 Angewandte Infektions- und Krankenhaushygiene, Berlin, Germany.

J Gebel (J)

Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany; VAH Ring Trial Steering Committee of the Association for Applied Hygiene (VAH), Bonn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH